The Merck “3 Baskets” approach, Future Market Insights report on the OOC market, Anivance AI selected by the FNIH NAMs pilot, OpenAI Foundation for Alzheimer, and more

NAMs News

Actus des méthodes non-animales

APRIL 20 - 24, 2026

Pro Anima > Actualités > NAMs News - APRIL 20 - 24, 2026
The Merck “3 Baskets” approach, Future Market Insights report on the OOC market, Anivance AI selected by the FNIH NAMs pilot, OpenAI Foundation for Alzheimer, and more
NAMs News - APRIL 06 - 10 2026

Standardizing NAMs, 2025 ECVAM Status Report, Anthropic’s life sciences strategy, Non-clinical safety assessment of vaccines, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Novo Nordisk principal scientist highlights the urgency of advancing human-relevant 3D tissue models As […]

Read more
NAMs News - MARCH 30 - APRIL 03, 2026

UK regulatory guidance for NAMs, Nature collection on organoid models for infectious diseases, AI agents in drug discovery and more

NEWS, REPORTS & POSITION STATEMENTS 1. UK: MHRA published guidance on its approach to medicines developed using non-animal methods The […]

Read more
NAMs News - MARCH 23 - 27, 2026

FDA draft guidance on NAMs for industry, NIH’s $150 million investment, Swiss 3RCC report, PEPPER call for partner laboratories, Cell-Microgel Biohybrid Spheroids, and more

NEWS, REPORTS & POSITION STATEMENTS 1. FDA: General considerations for the use of NAMs in drug development The Food and […]

Read more
NAMs News - MARCH 16 - 20, 2026

Agentic AI in biomedical research, Two decades of iPSC research, Vascularizing OOC, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Agentic AI and the rise of in silico team science in biomedical research Agentic […]

Read more
NAMs News - MARCH 09 - 13, 2026

AI-Ready evaluation for Antimicrobial Resistance Research, BEACON consortium, Bruker x Noetik spatial AI models, iPSC-derived multi-organ PK/PD, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Global community effort to shape new AI-ready datasets and evaluations for Antimicrobial Resistance Research […]

Read more
NAMs News - March 02 - 06, 2026

NAMs Landscape in India, French LIFT Industrial Chair, VISI-ON-BRAIN doctoral network, A human mini-bladder, and more

NEWS, REPORTS & POSITION STATEMENTS 1. India: Landscape analysis on alternatives for drug development The landscape of drug development is […]

Read more
NAMs News - FEBRUARY 23 - 27, 2026

World’s first iPSC-derived drugs approval in Japan, ERA Act, Innovate UK funding, Roche new high-tech center, Human spinal cord organoids, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Japan endorses two iPSC-derived drugs for approval Japan, through a Ministry of Health committee, […]

Read more
NAMs News - FEBRUARY 16 - 20, 2026

Modern risks assessments, Human relevant pre-clinical models, Big pharma’s China deal wave, Intelligent sensors cell production, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Transforming chemicals and cosmetics assessment Carcinogenicity assessment Assessing the safety of chemicals used in […]

Read more
NAMs News - FEBRUARY 09 - 13, 2026

EU IVB competitiveness, IAMPS launch, 2027 DVES Prize call, Industrializing global cell therapy, Big Data and T2 Diabetes, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Strengthening the competitiveness of EU in vitro biotechnologies In vitro biotechnology (IVB) is a […]

Read more
NAMs News - FEBRUARY 02 - 06, 2026

US EPA to replace animal testing by 2035, NATs for Vet research, Advanced human skin models, Brain chips in neurology, and more

NEWS, REPORTS & POSITION STATEMENTS 1. US EPA recommits to eliminate animal testing for chemical safety by 2035 In 2019, the […]

Read more
NAMs News - JANUARY 26 - 30, 2026

AI to assess chemicals, India: AI Center of excellence, The largest dataset for Virtual Cell Modeling, Vascularised organoids, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Challenges and opportunities for human OOC in FDA assessments and pharma pipelines The US […]

Read more
NAMs News - JANUARY 19 - 23, 2026

Animal-free endotoxins test, Common principles for AI, Bioprinted organs on demand, Multi-omics qualification of an OOC model, and more

NEWS, REPORTS & POSITION STATEMENTS 1. Endotoxin testing milestone reached with European Pharmacopoeia’s animal shift From 1 January 2026, EU […]

Read more
Donate
MENU